| Issue |
Section |
Title |
File |
| Vol 16, No 3 (2017) |
Статьи |
The results of pilot trial ALL-REZ-MВ-2014 for children with relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 17, No 4 (2018) |
ORIGINAL ARTICLES |
Hhe results of different antibodies application for CD1a expression evaluation in pediatric t-lineage all |
(Rus)
|
| Vol 17, No 4 (2018) |
CLINICAL SIGNIFICANCE OF BASIC RESEARCH |
Flow cytometric measurement of absolute telomere length |
(Rus)
|
| Vol 18, No 1 (2019) |
PROMISING STUDIES |
First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
Immunophenotypic characteristics of early T-cell precursor acute lymphoblastic leukemia |
(Rus)
|
| Vol 18, No 2 (2019) |
CLINICAL OBSERVATIONS |
The phenomenon of conversion of the donor-derived blood group to the patient’s original blood group after ABO-incompatible hematopoietic stem cell transplantation in a patient with Wiskott–Aldrich syndrome |
(Rus)
|
| Vol 18, No 3 (2019) |
ORIGINAL ARTICLES |
Immunophenotypic characterization of acute megakaryoblastic leukaemia in children |
(Rus)
|
| Vol 19, No 1 (2020) |
ORIGINAL ARTICLES |
The influence of a dosage regimen of dexamethasone on detection of normal B-cell precursors in the bone marrow of children with BCP-ALL at the end of induction therapy |
(Rus)
|
| Vol 20, No 1 (2021) |
PROMISING STUDIES |
Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Prognostic significance of various 11q23/KMT2A rearrangements in infants with acute lymphoblastic leuekemia |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Immunophenotypic characterization of pediatric acute myeloid leukemia with inv(16)(p13.1q22)/t(16;16)(p13.1;q22)/CBFb-MYH11 |
(Rus)
|
| Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
A hypodiploid karyotype in childhood B-cell precursor acute lymphoblastic leukemia |
(Rus)
|
| Vol 20, No 2 (2021) |
CLINICAL OBSERVATIONS |
CNS relapse of B-lymphoblastic lymphoma after allogeneic hematopoietic stem cell transplantation: therapy with donor CD19-specific CAR-T cells |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
The diagnostics of blastic plasmocytoid dendritic cell neoplasm: report of five cases |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
Low specificity of HLA-DR expression for diagnosis of acute promyelocytic leukemia |
(Rus)
|
| Vol 21, No 3 (2022) |
CLINICAL OBSERVATIONS |
Acute lymphoblastic leukemia with the t(17;19) translocation: hope has appeared! Multimodal immunotherapy in a 3-year-old child with refractory disease: a case report |
(Rus)
|
| Vol 22, No 1 (2023) |
PROMISING STUDIES |
The use of droplet digital polymerase chain reaction for the molecular diagnosis and monitoring of treatment response in patients with Langerhans cell histiocytosis with the BRAF V600E mutation |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience |
(Rus)
|
| Vol 22, No 1 (2023) |
DIAGNOSTIC GUIDELINES |
Flow cytometry in acute leukemia diagnostics. Guidelines of Russian-Belarusian multicenter group for pediatric leukemia studies |
(Rus)
|
| Vol 22, No 2 (2023) |
DIAGNOSTIC GUIDELINES |
Guidelines for the flow cytometric minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia after CD19-directed immunotherapy |
(Rus)
|
| Vol 22, No 3 (2023) |
ORIGINAL ARTICLES |
The results of therapy with venetoclax, daratumumab and plerixafor as part of the conditioning regimen in chemotherapy-refractory acute leukemia in children |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The results of a study on the effectiveness 37 and safety of treatment with vemurafenib and cytarabine/2-chloro-2′-deoxyadenosine combination in patients with Langerhans cell histiocytosis with BRAFV600E mutation |
(Rus)
|
| Vol 22, No 3 (2023) |
DIAGNOSTIC GUIDELINES |
Minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia using flow cytometry. Guidelines of the Russian-Belarusian multicenter group for pediatric acute leukemia studies |
(Rus)
|
| Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 4 (2023) |
DIAGNOSTIC GUIDELINES |
Guidelines for the use of flow cell sorting in diagnosis and monitoring of acute leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slow clearance of minimal residual disease |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with acute myeloid leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
DIAGNOSTIC GUIDELINES |
Immunophenotyping in the diagnosis of acute leukemias of ambiguous lineage. The results of centralized diagnosis and practical guidelines |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Transient abnormal myelopoiesis, myelodysplastic syndrome and acute myeloid leukemia in children with Down syndrome |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
The results of a registry study on acute myeloid leukemia in Russian children |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
The prognostic value of FLT3-ITD in different cytogenetic and molecular genetic subgroups of pediatric acute myeloid leukemia |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Leukemia with L3 morphology: cytogenetic characterization and diagnostic challenges |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pediatric non-Down syndrome acute megakaryoblastic leukemia with GATA1 mutations |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Preliminary results of treatment of intermediate-risk patients according to the AML-MRD-2018 protocol |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Outcomes of treatment of childhood acute promyelocytic leukemia according to the APL 2003/2008 protocols in Russia and Belarus |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pegylated asparaginase during induction therapy in children with intermediate-risk acute lymphoblastic leukemia: results of a randomized study |
(Rus)
|
| Vol 24, No 1 (2025) |
CLINICAL OBSERVATIONS |
Acute myeloid leukemia with translocations involving the KMT2A gene in twins as a model for the study of leukemogenesis: clinical case reports and genetic characteristics |
(Rus)
|
